Ritholtz Wealth Management Decreases Position in HCA Healthcare, Inc. (NYSE:HCA)

Ritholtz Wealth Management trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,747 shares of the company’s stock after selling 271 shares during the quarter. Ritholtz Wealth Management’s holdings in HCA Healthcare were worth $3,555,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Bangor Savings Bank grew its stake in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC increased its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare in the 2nd quarter valued at about $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.9 %

Shares of NYSE:HCA opened at $394.54 on Friday. The firm has a 50 day simple moving average of $387.15 and a 200-day simple moving average of $347.49. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $409.42. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a market capitalization of $103.34 billion, a PE ratio of 19.67, a P/E/G ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm earned $4.29 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. HCA Healthcare’s payout ratio is 13.16%.

Analysts Set New Price Targets

A number of research analysts recently commented on HCA shares. KeyCorp started coverage on HCA Healthcare in a report on Friday. They issued an “overweight” rating and a $475.00 price objective on the stock. Leerink Partners boosted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 30th. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Finally, Truist Financial lifted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $365.65.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock worth $6,407,273 over the last 90 days. 1.60% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.